Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation

Sissel J Moltu1, Daniel Sachse2, Elin W Blakstad3

  • 1Department of Pediatrics, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway. sissel.moltu@medisin.uio.no.

Nutrients
|May 15, 2014
PubMed

Insights

Enhanced nutrition in premature infants did not alter urine metabolite profiles significantly. However, specific amino acids and metabolites changed with infant maturation, and elevated glycine and threonine in early urine may indicate altered metabolic phenotypes in small for gestational age infants.

Area of Science:

  • Nutritional science
  • Metabolomics
  • Neonatal research

Background:

  • Early nutrition is crucial for metabolic programming and long-term health in infants.
  • Premature infants (<1500 g) require specialized nutritional support during hospitalization.
  • Understanding metabolic adaptations in preterm infants is essential for optimizing growth and development.

Purpose of the Study:

  • To investigate the impact of enhanced neonatal nutrition on urinary metabolite profiles in premature infants.
  • To identify potential metabolic biomarkers associated with infant growth and maturation.
  • To explore the relationship between early nutrition and metabolic programming in preterm neonates.

Main Methods:

  • A randomized controlled trial involving 48 premature infants.
  • Comparison of an enhanced diet versus a standard diet.
  • Urinary metabolite profiling using nuclear magnetic resonance (NMR) spectroscopy at different time points.

Main Results:

  • Enhanced nutrition provided higher energy, protein, lipids, and specific vitamins/fatty acids.
  • Urinary metabolite profiles showed significant changes related to postmenstrual age, including increases in glucogenic amino acids and TCA cycle metabolites.
  • Elevated glycine and threonine were observed in the first-week urine of small for gestational age (SGA) infants.

Conclusions:

  • Nutri-metabolomics in preterm infants reveals metabolic changes influenced by physiological adaptation and maturation.
  • Elevated glycine and threonine in early urine samples of SGA infants may serve as potential biomarkers for altered metabolic phenotypes.
  • This study highlights the complex interplay between early nutrition, maturation, and metabolism in premature infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
2.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
513